InnovaDerma has acquired 3 companies.
InnovaDerma’s largest acquisition to date was in 2017, when it acquired Ergon Medical for $2M. InnovaDerma has acquired in 2 countries. The Company’s most targeted sectors include consumer products (67%) and medical products (34%).
27 Old Gloucester Street,
London,
WC1N 3AX
United Kingdom,
800 014 8895
www.innovaderma.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2017-05-02 |
Ergon Medical Ltd. (Prolong) · Medical Products
East Sussex, United Kingdom Ergon Medical Ltd. the owner of the intellectual property rights of ProlongTM, the world's only medical device cleared by the U.S. Food & Drug Administration ("FDA") for premature ejaculation. Prolong is a Class II vibrating medical device as classified by the FDA and used as part of a climax control programme for males who suffer from premature ejaculation. It is designed to increase the time between arousal and ejaculation through the use of the training sessions using the stimulating vibratory effects of the device on the penis as part of the "Start-Stop" technique. Prolong offers an affordable, pain-free, one-off, or long-term treatment option with no side effects. |
2 | Add-on Acquisition | - |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
